New Humana Healthcare Research Study Finds Favorable Selection in Medicare Advantage is Substantially Lower Than MedPAC Estimates

Humana upgraded to outperform at Evercore on growth prospects

Evercore ISI upgrades Humana to outperform on Medicare growth and 4-star ratings upside potential. Read more here.

Humana tops quarterly estimates, maintains profit outlook as medical costs stay in line

Humana maintained its 2026 adjusted profit outlook of at least $9 per share, which some analysts called a "disappointment" amid high expectations for insurers.

Humana Profits Hit $694 Million As Medicare Costs Fall In Line

Humana reported second quarter net income of $694 million as costs of care for older adults in its Medicare Advantage plans fell in line with company expectations.

Humana slashed its annual profit forecast as lower Medicare ratings squeezed bonuses

The health insurer revised its full-year GAAP earnings guidance to at least $6.52 a share, down from at least $8.36

Humana beats quarterly profit estimates as medical costs stay in line

July 29 (Reuters) - Humana on Wednesday beat ​Wall ‌Street estimates for second-quarter profit as ‌the ​health ⁠insurer's spend ⁠on medical services was in line with ​expectations.    On an ⁠adjusted ⁠basis, the ​company earned ​a profit of $7.61 ‌per ...

New Humana Healthcare Research Study Finds Favorable Selection in Medicare Advantage is Substantially Lower Than MedPAC Estimates

LOUISVILLE, Ky.--(BUSINESS WIRE)--Jul 28, 2026-